+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Healthcare Infection Surveillance Service Market by End User (Ambulatory Surgery Centers, Clinics, Diagnostic Laboratories), Deployment Mode (Cloud, On Premise), Product Type, Infection Type - Global Forecast 2025-2030- Product Image
Healthcare Infection Surveillance Service Market by End User (Ambulatory Surgery Centers, Clinics, Diagnostic Laboratories), Deployment Mode (Cloud, On Premise), Product Type, Infection Type - Global Forecast 2025-2030- Product Image
New

Healthcare Infection Surveillance Service Market by End User (Ambulatory Surgery Centers, Clinics, Diagnostic Laboratories), Deployment Mode (Cloud, On Premise), Product Type, Infection Type - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6142164
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Setting the Stage for Proactive Healthcare Infection Surveillance Service Adoption with an Emphasis on Innovation and Patient Safety Across Care Continuum

Healthcare-associated infections continue to challenge patient safety, operational efficiency, and organizational reputation. Rising regulatory scrutiny and evolving care models, including the expansion of outpatient services and long-term care, have amplified the need for comprehensive surveillance capabilities. In response, healthcare providers are increasingly seeking integrated end-to-end solutions that span ambulatory surgery centers, diagnostic laboratories, primary and specialty clinics, as well as private and public hospitals. This landscape demands visibility across a fragmented care continuum that includes nursing homes and rehabilitation centers, all underpinned by a shared objective: early detection and rapid response to infection risks.

As clinical and administrative stakeholders navigate these complexities, the imperative for data-driven decision-making has never been stronger. Today’s surveillance services leverage advanced analytics, real-time reporting, and interoperability standards to generate timely insights that inform both clinical protocols and operational policies. This executive summary frames the critical drivers, emerging shifts, and competitive dynamics shaping the adoption of infection surveillance services, offering a foundational overview designed for decision-makers committed to elevating patient outcomes and safeguarding institutional integrity.

Examining the Emergence of Cloud-Enabled and Analytics-Driven Surveillance Solutions Transforming Infection Control Across Diverse Healthcare Environments

The infection surveillance service landscape is undergoing a profound transformation driven by the convergence of cloud computing and advanced analytics. Organizations are migrating from legacy on-premise architectures to scalable cloud-native deployments, unlocking real-time data aggregation from disparate sources. By harnessing prescriptive and predictive models, surveillance systems now transcend traditional threshold alerts, enabling anticipatory interventions that can forestall outbreak scenarios before they emerge.

Moreover, the integration of artificial intelligence and machine learning algorithms has redefined diagnostic precision. Descriptive analytics consolidate historical data to reveal infection trends, while predictive algorithms forecast potential hotspots, guiding resource allocation. Operating beyond compliance-driven reporting, modern solutions incorporate operational and clinical insights that refine care pathways. This shift toward continuous monitoring and systemic intelligence empowers healthcare teams to transition from reactive containment to proactive stewardship, setting a new standard in infection control across every care setting.

Analyzing How Tariff Adjustments in 2025 Will Reshape Procurement Strategies for Infection Surveillance Service Technologies in US Healthcare Infrastructure

The imposition of tariffs on medical technologies and associated software services in 2025 has introduced notable complexities for procurement strategies in the United States. Organizations are recalibrating their sourcing models, evaluating the trade-offs between direct imports of advanced analytics platforms versus locally hosted alternatives. As duty rates influence total cost of ownership, healthcare systems are pursuing vendor partnerships that offer bundled service agreements and flexible licensing structures, effectively insulating them from abrupt price escalations.

In parallel, supply chain optimization has emerged as a critical countermeasure to mitigate the financial impact of tariffs. Stakeholders are diversifying their vendor portfolios, engaging domestic technology integrators to secure faster deployment timelines and predictable post-deployment support. Collaborative purchasing consortia are also gaining traction, leveraging collective bargaining power to negotiate favorable terms. These strategic adaptations underscore the sector’s resilience and its commitment to preserving patient safety imperatives even amid shifting trade policies.

Unveiling Critical Segmentation Insights Highlighting End User, Deployment Mode, Product Type, and Infection Type Dynamics Driving Service Optimization

Deep insights emerge when examining how different segments shape adoption patterns within infection surveillance services. End users span from ambulatory surgery centers to private and public hospitals, encompassing diagnostic laboratories and long-term care facilities. Within clinical practices, primary care environments prioritize streamlined workflows and rapid reporting, while specialty clinics demand tailored analytics for procedure-specific risk profiles. Hospital networks, both private and public, seek enterprise-grade platforms that align with their broader IT architectures, and nursing homes and rehabilitation centers emphasize ease of use and remote monitoring capabilities.

Deployment preferences reveal a clear bifurcation between cloud-hosted solutions that offer scalability and continuous updates, and on-premise installations that maintain direct infrastructure control. Product portfolios balance services and solutions: consulting, support, and training services complement robust analytics, reporting, and surveillance software. Analytics modules range from descriptive dashboards to predictive risk models and prescriptive intervention recommendations. Reporting tools cover compliance and operational metrics, reinforcing oversight frameworks. Finally, infection type segmentation-covering bloodstream, respiratory, surgical site, and urinary tract infections-ensures that stakeholders can tailor surveillance protocols to bacterial and viral pathogens, including tuberculosis, COVID-19, influenza, and a variety of surgical site subtypes.

Exploring Regional Variations and Growth Trajectories in the Americas, Europe Middle East Africa, and Asia-Pacific Healthcare Surveillance Ecosystems

Regional market dynamics reflect distinct care delivery frameworks and regulatory environments. In the Americas, healthcare networks leverage mature IT infrastructures and reimbursement incentives to accelerate the adoption of advanced surveillance platforms. Cross-border partnerships with technology integrators and emphasis on value-based care models drive innovation, particularly in the United States and Canada.

Europe, the Middle East, and Africa present a mosaic of national healthcare systems with varied digital maturity levels. Countries in Western Europe lead in standardized data exchanges and compliance mandates, while emerging markets in the Middle East and Africa demonstrate growing interest in cloud deployments to overcome legacy constraints. Collaborative initiatives between public health agencies and private providers foster pilot programs that showcase predictive analytics in infection control.

In Asia-Pacific, dynamic population densities and diverse healthcare infrastructures catalyze rapid technology adoption. Leading markets invest heavily in AI-enabled surveillance, driving partnerships with global software vendors and local system integrators. Southeast Asian and Oceanic regions exhibit momentum in remote monitoring solutions, responding to the dual pressures of pandemic preparedness and long-term care expansion.

Spotlighting Leading Industry Players and Their Strategic Movements Driving Advancements and Competitive Differentiation in Infection Surveillance Services

Leading industry players are executing strategic maneuvers to consolidate their positions and expand market reach. Established software developers continue to augment their portfolios through targeted acquisitions of niche analytics startups, bolstering predictive and prescriptive capabilities. Convergence between traditional medical device manufacturers and technology firms is driving the co-development of integrated surveillance platforms that unify digital diagnostics with clinical decision support.

At the same time, emerging providers are differentiating via specialized support services and outcome-based contracts, forging partnerships with large hospital systems and insurance payers. Collaborative alliances with laboratory networks ensure real-time pathogen data feeds, while alliances with academic institutions facilitate the validation of machine learning models. This ecosystem of co-innovation is enabling a wave of modular, interoperable solutions designed to align with heterogeneous IT environments.

Presenting Strategic and Actionable Recommendations for Healthcare Leaders to Enhance Infection Surveillance, Optimize Operations, and Elevate Patient Outcomes

Organizations seeking to strengthen their infection surveillance initiatives should prioritize a phased approach that begins with a comprehensive technology audit to identify existing gaps in data integration and reporting workflows. Subsequently, investing in cloud-native architectures will provide scalability and rapid access to feature enhancements. In parallel, leaders should establish interdisciplinary governance councils that bring together infection prevention experts, IT professionals, and clinical stakeholders to guide implementation and policy refinement.

Further, adopting outcome-based service agreements with vendors can align incentives for continuous performance improvements and ensure accountability for system uptime and data accuracy. To maximize the value of analytics, healthcare teams must engage in regular training programs that build proficiency in interpreting predictive insights. Finally, forging strategic alliances with diagnostic laboratories and public health agencies will enhance early warning capabilities, enabling a proactive stance that safeguards patient wellbeing and mitigates institutional financial exposure in the face of emerging infectious threats.

Detailing a Rigorous Multi-Source Research Methodology Integrating Primary Interviews and Secondary Literature to Validate Surveillance Service Insights

This analysis draws upon a robust multi-tiered research framework that integrates extensive secondary research with targeted primary engagements. The secondary phase encompassed a thorough review of regulatory guidelines, industry white papers, peer-reviewed journals, and technology vendor literature to map the current state of infection surveillance services. Key themes and technology trends were distilled through systematic content analysis, providing foundational context for subsequent inquiry.

During the primary phase, in-depth interviews were conducted with senior IT executives, infection control specialists, and clinical operations leaders across diverse geographical regions. These conversations validated secondary findings, surfaced nuanced adoption drivers, and revealed practical implementation challenges. Data triangulation was achieved through cross-referencing interview insights with real-world case studies and validated performance benchmarks. Rigorous quality control measures, including peer reviews and methodological audits, ensured the reliability and accuracy of the conclusions presented.

Summarizing Key Takeaways and Reinforcing the Strategic Importance of Advanced Infection Surveillance Service Adoption Across Care Settings

In conclusion, the trajectory of healthcare infection surveillance services is defined by an unrelenting drive toward predictive intelligence, seamless interoperability, and adaptive deployment models. As tariff realities and regional variances introduce complexity, organizations that embrace strategic procurement, foster interdisciplinary collaboration, and invest in cloud-enabled analytics will emerge as market leaders. The interplay of end-user preferences, deployment architectures, and specialized product capabilities underscores the importance of a holistic, data-informed approach to infection prevention.

By integrating advanced surveillance solutions into the fabric of clinical and operational decision-making, healthcare providers can achieve superior outcomes, mitigate risk exposures, and align with evolving regulatory mandates. The insights and recommendations offered herein aim to equip stakeholders with the strategic foresight needed to navigate a rapidly evolving landscape and to chart a course toward sustained performance and enhanced patient safety.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • End User
    • Ambulatory Surgery Centers
    • Clinics
      • Primary Care Clinics
      • Specialty Clinics
    • Diagnostic Laboratories
    • Hospitals
      • Private Hospitals
      • Public Hospitals
    • Long Term Care Facilities
      • Nursing Homes
      • Rehabilitation Centers
  • Deployment Mode
    • Cloud
    • On Premise
  • Product Type
    • Services
      • Consulting Services
      • Support Services
      • Training
    • Solutions
      • Analytics Software
        • Descriptive Analytics
        • Predictive Analytics
        • Prescriptive Analytics
      • Reporting Software
        • Compliance Reporting Tools
        • Operational Reporting Tools
      • Surveillance Software
  • Infection Type
    • Bloodstream Infections
    • Respiratory Infections
      • Bacterial Infections
        • Tuberculosis
      • Viral Infections
        • COVID-19
        • Influenza
    • Surgical Site Infections
      • Cardiothoracic Surgery
      • General Surgery
      • Orthopedic Surgery
    • Urinary Tract Infections
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Thermo Fisher Scientific, Inc.
  • Becton, Dickinson and Company
  • bioMérieux SA
  • F. Hoffmann-La Roche Ltd
  • SAS Institute Inc.
  • Oracle Corporation
  • Epic Systems Corporation
  • Wolters Kluwer N.V.
  • IBM Corporation
  • SCC Soft Computer, Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of AI-driven predictive analytics into hospital infection control workflows to proactively identify and mitigate infection risks
5.2. Adoption of cloud-based real-time infection surveillance platforms to enhance cross-facility data sharing and response coordination
5.3. Utilization of IoT-enabled smart sensors and wearable devices for continuous monitoring of hospital-acquired infection indicators
5.4. Expansion of remote infection surveillance capabilities leveraging telehealth and mobile applications for community care monitoring
5.5. Implementation of standardized interoperability protocols for seamless electronic health record integration in infection surveillance systems
5.6. Growing emphasis on antimicrobial stewardship integration with surveillance tools to optimize antibiotic usage and reduce resistance development
5.7. Increasing regulatory mandates for public reporting of healthcare-associated infection metrics driving surveillance adoption and compliance strategies
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Healthcare Infection Surveillance Service Market, by End User
8.1. Introduction
8.2. Ambulatory Surgery Centers
8.3. Clinics
8.3.1. Primary Care Clinics
8.3.2. Specialty Clinics
8.4. Diagnostic Laboratories
8.5. Hospitals
8.5.1. Private Hospitals
8.5.2. Public Hospitals
8.6. Long Term Care Facilities
8.6.1. Nursing Homes
8.6.2. Rehabilitation Centers
9. Healthcare Infection Surveillance Service Market, by Deployment Mode
9.1. Introduction
9.2. Cloud
9.3. On Premise
10. Healthcare Infection Surveillance Service Market, by Product Type
10.1. Introduction
10.2. Services
10.2.1. Consulting Services
10.2.2. Support Services
10.2.3. Training
10.3. Solutions
10.3.1. Analytics Software
10.3.1.1. Descriptive Analytics
10.3.1.2. Predictive Analytics
10.3.1.3. Prescriptive Analytics
10.3.2. Reporting Software
10.3.2.1. Compliance Reporting Tools
10.3.2.2. Operational Reporting Tools
10.3.3. Surveillance Software
11. Healthcare Infection Surveillance Service Market, by Infection Type
11.1. Introduction
11.2. Bloodstream Infections
11.3. Respiratory Infections
11.3.1. Bacterial Infections
11.3.1.1. Tuberculosis
11.3.2. Viral Infections
11.3.2.1. COVID-19
11.3.2.2. Influenza
11.4. Surgical Site Infections
11.4.1. Cardiothoracic Surgery
11.4.2. General Surgery
11.4.3. Orthopedic Surgery
11.5. Urinary Tract Infections
12. Americas Healthcare Infection Surveillance Service Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Healthcare Infection Surveillance Service Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Healthcare Infection Surveillance Service Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Thermo Fisher Scientific, Inc.
15.3.2. Becton, Dickinson and Company
15.3.3. bioMérieux SA
15.3.4. F. Hoffmann-La Roche Ltd
15.3.5. SAS Institute Inc.
15.3.6. Oracle Corporation
15.3.7. Epic Systems Corporation
15.3.8. Wolters Kluwer N.V.
15.3.9. IBM Corporation
15.3.10. SCC Soft Computer, Inc.
16. Research AI17. Research Statistics18. Research Contacts19. Research Articles20. Appendix
List of Figures
FIGURE 1. HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 6. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY INFECTION TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY INFECTION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET: RESEARCHAI
FIGURE 24. HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET: RESEARCHSTATISTICS
FIGURE 25. HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET: RESEARCHCONTACTS
FIGURE 26. HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY PRIMARY CARE CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY PRIMARY CARE CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY LONG TERM CARE FACILITIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY LONG TERM CARE FACILITIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY NURSING HOMES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY NURSING HOMES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY LONG TERM CARE FACILITIES, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY LONG TERM CARE FACILITIES, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY CLOUD, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY CLOUD, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY ON PREMISE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY ON PREMISE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SUPPORT SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SUPPORT SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY TRAINING, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY TRAINING, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SOLUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SOLUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY ANALYTICS SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY ANALYTICS SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY DESCRIPTIVE ANALYTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY DESCRIPTIVE ANALYTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY PREDICTIVE ANALYTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY PREDICTIVE ANALYTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY PRESCRIPTIVE ANALYTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY PRESCRIPTIVE ANALYTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY ANALYTICS SOFTWARE, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY ANALYTICS SOFTWARE, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY REPORTING SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY REPORTING SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY COMPLIANCE REPORTING TOOLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY COMPLIANCE REPORTING TOOLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY OPERATIONAL REPORTING TOOLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY OPERATIONAL REPORTING TOOLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY REPORTING SOFTWARE, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY REPORTING SOFTWARE, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SURVEILLANCE SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SURVEILLANCE SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY INFECTION TYPE, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY INFECTION TYPE, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY BLOODSTREAM INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY BLOODSTREAM INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY RESPIRATORY INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY RESPIRATORY INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY BACTERIAL INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY BACTERIAL INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY TUBERCULOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY TUBERCULOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY BACTERIAL INFECTIONS, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY VIRAL INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY VIRAL INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY COVID-19, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY COVID-19, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY INFLUENZA, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY INFLUENZA, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY VIRAL INFECTIONS, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY VIRAL INFECTIONS, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SURGICAL SITE INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SURGICAL SITE INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY CARDIOTHORACIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY CARDIOTHORACIC SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SURGICAL SITE INFECTIONS, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SURGICAL SITE INFECTIONS, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY LONG TERM CARE FACILITIES, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY LONG TERM CARE FACILITIES, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY ANALYTICS SOFTWARE, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY ANALYTICS SOFTWARE, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY REPORTING SOFTWARE, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY REPORTING SOFTWARE, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY INFECTION TYPE, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY INFECTION TYPE, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY BACTERIAL INFECTIONS, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY VIRAL INFECTIONS, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY VIRAL INFECTIONS, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SURGICAL SITE INFECTIONS, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SURGICAL SITE INFECTIONS, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY LONG TERM CARE FACILITIES, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY LONG TERM CARE FACILITIES, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY ANALYTICS SOFTWARE, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY ANALYTICS SOFTWARE, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY REPORTING SOFTWARE, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY REPORTING SOFTWARE, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY INFECTION TYPE, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY INFECTION TYPE, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY BACTERIAL INFECTIONS, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY VIRAL INFECTIONS, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY VIRAL INFECTIONS, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SURGICAL SITE INFECTIONS, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SURGICAL SITE INFECTIONS, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 179. CANADA HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. CANADA HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. CANADA HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 182. CANADA HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 183. CANADA HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 184. CANADA HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 185. CANADA HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY LONG TERM CARE FACILITIES, 2018-2024 (USD MILLION)
TABLE 186. CANADA HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY LONG TERM CARE FACILITIES, 2025-2030 (USD MILLION)
TABLE 187. CANADA HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 188. CANADA HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 189. CANADA HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 190. CANADA HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 191. CANADA HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 192. CANADA HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 193. CANADA HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 194. CANADA HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 195. CANADA HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY ANALYTICS SOFTWARE, 2018-2024 (USD MILLION)
TABLE 196. CANADA HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY ANALYTICS SOFTWARE, 2025-2030 (USD MILLION)
TABLE 197. CANADA HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY REPORTING SOFTWARE, 2018-2024 (USD MILLION)
TABLE 198. CANADA HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY REPORTING SOFTWARE, 2025-2030 (USD MILLION)
TABLE 199. CANADA HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY INFECTION TYPE, 2018-2024 (USD MILLION)
TABLE 200. CANADA HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY INFECTION TYPE, 2025-2030 (USD MILLION)
TABLE 201. CANADA HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 202. CANADA HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 203. CANADA HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2024 (USD MILLION)
TABLE 204. CANADA HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY BACTERIAL INFECTIONS, 2025-2030 (USD MILLION)
TABLE 205. CANADA HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY VIRAL INFECTIONS, 2018-2024 (USD MILLION)
TABLE 206. CANADA HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY VIRAL INFECTIONS, 2025-2030 (USD MILLION)
TABLE 207. CANADA HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SURGICAL SITE INFECTIONS, 2018-2024 (USD MILLION)
TABLE 208. CANADA HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SURGICAL SITE INFECTIONS, 2025-2030 (USD MILLION)
TABLE 209. MEXICO HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. MEXICO HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. MEXICO HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 212. MEXICO HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 213. MEXICO HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 214. MEXICO HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 215. MEXICO HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY LONG TERM CARE FACILITIES, 2018-2024 (USD MILLION)
TABLE 216. MEXICO HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY LONG TERM CARE FACILITIES, 2025-2030 (USD MILLION)
TABLE 217. MEXICO HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 218. MEXICO HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 219. MEXICO HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 220. MEXICO HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 221. MEXICO HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 222. MEXICO HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 223. MEXICO HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 224. MEXICO HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 225. MEXICO HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY ANALYTICS SOFTWARE, 2018-2024 (USD MILLION)
TABLE 226. MEXICO HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY ANALYTICS SOFTWARE, 2025-2030 (USD MILLION)
TABLE 227. MEXICO HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY REPORTING SOFTWARE, 2018-2024 (USD MILLION)
TABLE 228. MEXICO HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY REPORTING SOFTWARE, 2025-2030 (USD MILLION)
TABLE 229. MEXICO HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY INFECTION TYPE, 2018-2024 (USD MILLION)
TABLE 230. MEXICO HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY INFECTION TYPE, 2025-2030 (USD MILLION)
TABLE 231. MEXICO HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 232. MEXICO HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 233. MEXICO HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2024 (USD MILLION)
TABLE 234. MEXICO HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY BACTERIAL INFECTIONS, 2025-2030 (USD MILLION)
TABLE 235. MEXICO HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY VIRAL INFECTIONS, 2018-2024 (USD MILLION)
TABLE 236. MEXICO HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY VIRAL INFECTIONS, 2025-2030 (USD MILLION)
TABLE 237. MEXICO HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SURGICAL SITE INFECTIONS, 2018-2024 (USD MILLION)
TABLE 238. MEXICO HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SURGICAL SITE INFECTIONS, 2025-2030 (USD MILLION)
TABLE 239. BRAZIL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. BRAZIL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY LONG TERM CARE FACILITIES, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY LONG TERM CARE FACILITIES, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY ANALYTICS SOFTWARE, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY ANALYTICS SOFTWARE, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY REPORTING SOFTWARE, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY REPORTING SOFTWARE, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY INFECTION TYPE, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY INFECTION TYPE, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY BACTERIAL INFECTIONS, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY VIRAL INFECTIONS, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY VIRAL INFECTIONS, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SURGICAL SITE INFECTIONS, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY SURGICAL SITE INFECTIONS, 2025-2030 (USD MILLION)
TABLE 269. ARGENTINA HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. ARGENTINA HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. ARGENTINA HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 272. ARGENTINA HEALTHCARE INFECTION SURVEILLANCE SERVICE MARKET SIZE, BY CLINICS,

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Healthcare Infection Surveillance Service Market report include:
  • Thermo Fisher Scientific, Inc.
  • Becton, Dickinson and Company
  • bioMérieux SA
  • F. Hoffmann-La Roche Ltd
  • SAS Institute Inc.
  • Oracle Corporation
  • Epic Systems Corporation
  • Wolters Kluwer N.V.
  • IBM Corporation
  • SCC Soft Computer, Inc.

Related Topics

Related Reports

Infection Surveillance Solution Market by Component (Services, Software), Deployment Mode (Cloud, On Premises), Technology, Application, End User - Global Forecast 2025-2030 - Product Image

Infection Surveillance Solution Market by Component (Services, Software), Deployment Mode (Cloud, On Premises), Technology, Application, End User - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Infection Surveillance Solutions Market Report by Component, Deployment Type, End User, and Region 2025-2033 - Product Image

Infection Surveillance Solutions Market Report by Component, Deployment Type, End User, and Region 2025-2033

  • Report
  • 141 Pages
  • Global
From
Infection Surveillance Solutions Market Size, Share and Trends Analysis Report by Component (Services, Software), End-use (Long Term Care Facilities, Hospitals, Clinics), and Region 2024-2030 - Product Image

Infection Surveillance Solutions Market Size, Share and Trends Analysis Report by Component (Services, Software), End-use (Long Term Care Facilities, Hospitals, Clinics), and Region 2024-2030

  • Report
  • 100 Pages
  • Global
From
Infection Surveillance Solutions - Global Strategic Business Report - Product Image

Infection Surveillance Solutions - Global Strategic Business Report

  • Report
  • 254 Pages
  • Global
From
Infection Surveillance Solutions - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Infection Surveillance Solutions - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 120 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.